Clinical trial
Clinical Study of Yiqi-yangyin-jiedu Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma Patients With Activating EGFR Mutation
NCT02929693 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Yiqi-yangyin-jiedu Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma Patients With Activating EGFR Mutation
- Lead sponsor
- Shanghai University of Traditional Chinese Medicine
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- June 30, 2019
- Enrollment
- 198 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer